Dr. Tarun K. Narang, MD

Dr. Narang practices at Carolina Digestive Health Associates PA - HOPD in Charlotte, North Carolina.

Dr. Narang's NPI, 1205904448, was assigned on December 4, 2006. Dr. Narang holds North Carolina license 2009-00143.

Dr. Narang's primary practice is Carolina Digestive Health Associates PA - HOPD, at 300 Billingsley Rd, Charlotte, NC 28211.

Dr. Narang's primary practice is Carolina Digestive Health Associates PA - HOPD in Charlotte, North Carolina. Dr. Narang is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Carolina Digestive Health Associates. Dmand AI also links Dr. Narang to 4 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Narang practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Narang's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Narang's licenses on file in 2 states: North Carolina and New York.

CMS data shows 3,523 Medicare services from Dr. Narang across 25 procedure codes in 2024, for 566 Medicare patients. Medicare paid $243,430 for them.

CMS counts 566 Medicare patients who saw Dr. Narang in 2024. The largest group is 65 to 74, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Narang's median patient age at 63, with 55% women.

In 2024, Dr. Narang wrote 1,289 Medicare Part D claims for 542 patients. 76% of them were for generic drugs. CMS names the drug for 1,181 of them, across 25 drugs with 11 or more claims each, at $536,648 in total drug cost. In 2023, CMS named 1,183 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Narang for performance year 2024, reported as part of a group. Dr. Narang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 790 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Narang, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 272 papers to Dr. Narang, published from 2010 to 2025. 2024 was the busiest year, with 26. The most frequent topics are Leprosy, India and Leprostatic Agents. Dr. Narang has published most often in Indian J Dermatol Venereol Leprol. Dr. Narang's most frequent co-authors are Anuradha Bishnoi, MBBS, MD, Sunil Kumar Gupta, MD and Mark William Russo, MD.

CMS Open Payments shows 907 general payments to Dr. Narang from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $3,443.